Cytovance® Biologics to Expand Production Capabilities in 2013
Published: Wednesday, January 30, 2013 Last Updated: Wednesday, January 30, 2013
Cytovance® Biologics, Inc. announced that it will expand its current mammalian production capabilities to include a 1,000L SUB bioreactor, a 5,000L stainless steel bioreactor and an automated fill/finish line.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.